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AbstrAct
Objectives To investigate the effect of adding point-
of-care (POC) susceptibility testing to POC culture 
on appropriate use of antibiotics as well as clinical 
and microbiological cure for patients with suspected 
uncomplicated urinary tract infection (UTI) in general 
practice.
Design Open, individually randomised controlled trial.
setting General practice.
Participants Women with suspected uncomplicated UTI, 
including elderly patients above 65, patients with recurrent 
UTI and patients with diabetes. The sample size calculation 
predicted 600 patients were needed.
Interventions Flexicult SSI-Urinary Kit was used for POC 
culture and susceptibility testing and ID Flexicult was used 
for POC culture only.
Main outcome measures Primary outcome: appropriate 
antibiotic prescribing on the day after consultation defined 
as either (1) patient with UTI: to prescribe a first-line 
antibiotic to which the infecting pathogen was susceptible 
or a second line if a first line could not be used or (2) 
patient without UTI: not to prescribe an antibiotic. UTI was 
defined by typical symptoms and significant growth in a 
reference urine culture performed at one of two external 
laboratories. Secondary outcomes: clinical cure on day five 
according to a 7-day symptom diary and microbiological 
cure on day 14. Logistic regression models taking into 
account clustering within practices were used for analysis.
results 20 general practices recruited 191 patients 
for culture and susceptibility testing and 172 for culture 
only. 63% of the patients had UTI and 12% of these 
were resistant to the most commonly used antibiotic, 
pivmecillinam. Patients randomised to culture only 
received significantly more appropriate treatment (OR: 
1.44 (95% CI 1.03 to 1.99), p=0.03). There was no 
significant difference in clinical or microbiological cure.
conclusions Adding POC susceptibility testing to POC 
culture did not improve antibiotic prescribing for patients 
with suspected uncomplicated UTI in general practice. 
Susceptibility testing should be reserved for patients at 
high risk of resistance and complications.
trial registration number NCT02323087; Results.
IntrODuctIOn
Urinary tract infection (UTI) is a common 
condition in general practice and the second 
leading cause for the prescribing of antibi-
otics.1 Resistance rates for the most common 
uropathogen, Escherichia coli, are rising, and 
the inappropriate prescription of antibiotics 
in primary care is known to lead to antibiotic 
resistance.2–4 Resistant strains of bacteria 
can cause treatment failure and prolonged 
symptoms.5–7 Many countries recommend 
diagnosing UTI based on symptoms and 
urine dipstick, but combinations of symp-
toms and dipstick have proven inaccurate in 
ruling UTI in or out.8 9 In Denmark, there 
is no national guideline for diagnosing UTI 
and doctors have varying strategies based on 
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strengths and limitations of this study
 ► This study was a diagnostic randomised controlled 
trial allowing for evaluation of patient-relevant 
outcomes.
 ► Bias in the interpretation process was low and 
allocation concealment was sufficient
 ► The study took place in general practice, which 
enhances applicability of our findings to other 
primary care settings.
 ► Inclusion criteria were quite broad and our findings 
may be applied to the majority of patients in general 
practice with suspected urinary tract infection.
 ► We did not succeed to recruit our  initially planned 
sample of patients, but enough patients were 
recruited to detect a significant difference between 
the groups.
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Figure 1 Inclusion flow chart.









  Age below 50 years 105 (55) 83 (48) NS
  Age 50 years or 
above
86 (45) 89 (52) NS
Number of days with symptoms
  Symptoms for less 
than 3 days
77 (41) 67 (40) NS
  Symptoms 3 days or 
more
109 (59) 101 (60) NS
Key symptoms (dysuria, frequency, urge)
  One or two key 
symptoms
75 (40) 67 (40) NS
  Three key symptoms 111 (60) 100 (60) NS
Complicating factors
  Any complicating 
factor
43 (26) 62 (38) 0.0209
  Elderly above 
65 years
34 (20) 50 (29) 0.0496
  Recurrent UTI 
(>3 past year)
11 (6) 6 (4) NS
  Uncomplicated 
diabetes
11 (6) 17 (10) NS
Reference culture and susceptibility test
  Significant growth of 
uropathogens (UTI)
100 (62) 104 (64) NS
  Trimethroprim 
resistance
27 (26) 21 (20) NS
  Sulfamethizole 
resistance
29 (29) 24 (24) NS
  Nitrofurantoine 
resistance
3 (3) 3 (4) NS
  Mecillinam resistance 
(pivmecillinam)
15 (14) 9 (9) NS
Numbers are total numbers with percentages in brackets.
NS, non-significant; UTI, urinary tract infection.
urine dipstick, microscopy, point-of-care (POC) culture 
and POC culture and susceptibility testing.10 11 Urine 
culture gives a definite answer for UTI in the symptom-
atic patient.12 However, sending urine to the microbio-
logical laboratory for culture and susceptibility testing 
can delay treatment for several days. POC tests for 
urine culture, and urine culture susceptibility testing 
are commercially available. They can provide a result 
within 24 hours, a delay to treatment which the majority 
of patients would accept.13 The Flexicult SSI-Urinary 
Kit is commonly used in general practice due to its ease 
of use and the fact that both culture and susceptibility 
testing can be performed on the same plate.14 Similar 
chromogenic agars for culture-only exist, but are less 
commonly used and have not been validated in general 
practice. The most commonly used antibiotics in 
Denmark for treatment of acute UTI are pivmecillinam 
and sulfamethizole. Resistance rates in E. coli isolates 
in urine from primary care in Denmark are approxi-
mately 30% for sulfamethizole and 5%–10% for pivme-
cillinam.15 Since other uropathogens can be inherently 
resistant to pivmecillinam, overall resistance would be 
expected to be 15%–20% for this drug. We hypothesised 
that performing a susceptibility test prior to initiation 
of treatment could target treatment to the individual 
patient, potentially reducing inappropriate antibiotic 
prescribing and leading to faster clinical recovery. This 
study aimed to investigate the effect of POC culture and 
susceptibility testing against POC culture only on the 
appropriate use of antibiotics and clinical and microbi-
ological cure for patients with suspected uncomplicated 
UTI in general practice.
MAterIAl AnD MethODs
Design
This study was an open, randomised controlled trial 
(RCT). Patients were individually randomised to having 
either POC culture and susceptibility testing or POC 
culture only performed. The design is described in detail 
in the published protocol.16
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Table 2 Comparison of primary and secondary outcomes between the randomisation groups
n OR (95% CI) p
Unadjusted analysis
  Odds for appropriate prescribing if culture only 341 1.44 (1.03 to 1.99) 0.0311
  Odds for being symptom free on day 5 if culture-only 308 0.91 (0.56 to 1.49) NS
  Odds for no significant bacteriuria on day 14 if culture only 144 1.15 (0.62 to 2.13) NS
Adjusted for complicating factors
  Odds for appropriate prescribing if culture only 324 1.65 (1.12 to 2.42) 0.0112
  Odds for being symptom-free on day five if culture only 293 0.89 (0.55 to 1.44) NS
  Odds for no significant bacteriuria on day 14 if culture only 140 1.23 (0.64 to 2.38) NS
Subgroup analysis (unadjusted)
  Odds for appropriate prescribing for young patients without comorbidities if 
culture only
222 1.79 (1.06 to 3.02) 0.0300
  Odds for appropriate prescribing for patients that were elderly, had diabetes 
or had recurrent UTI if culture only
102 1.37 (0.78 to 2.41) NS
OR, Odds for having a positive outcome if randomised to culture-only (ID Flexicult) compared with culture and susceptibility testing (Flexicult 
SSI-Urinary Kit).
NS, non-significant; UTI, urinary tract infection.
recruitment of practices
An invitation letter was mailed to 200 randomly selected 
general practices in the Copenhagen area with the aim of 
recruiting 50 general practitioners (GPs) with experience 
in using POC culture. The recruited GPs participated in 
a prestudy instruction course on handling and reading 
both POC tests and had to pass an online test measuring 
ability to diagnose UTI based on photographs of urine 
cultures prior to the inclusion of patients.
recruitment of patients
The inclusion criteria were: women, 18 years or older, 
presenting to their GP with dysuria, frequency or 
urgency, for 7 days or less and for which the GP suspected 
uncomplicated UTI, including elderly patients above 
65, patients with recurrent UTI and patients with orally 
treated diabetes without complications. The broader defi-
nition of uncomplicated UTI was chosen to ensure appli-
cability to a larger group of patients in general practice. 
The exclusion criteria were: negative dipstick analysis 
on both leucocytes and nitrites, serious comorbidities, 
former participation in the study and patients presenting 
on a Friday (since POC culture is read the following day). 
All patients had to consent to wait until the next day to 
receive the result of the POC test before commencing 
possible treatment. After informed consent, patients 
were randomised to either POC culture, or POC culture 
and susceptibility testing. A urine sample from the same 
portion of urine was sent to the local microbiological 
laboratory for culture and susceptibility testing. The GP 
filled out a case report form and the patient was asked 
to fill out a 7-day symptom diary and return to the GP 
after 14 days for a control urine sample. Validation of the 
symptom diary has previously been published.17 Patients 
were reminded by text messages and telephone calls to 
return the diary and bring the control urine sample. Each 
practice kept an anonymous screening log of patients 
who fulfilled the inclusion criteria but who were not 
included in the study. GPs received no treatment protocol 
concerning choice of antibiotics but could decide freely 
on treatment.
Patient involvement
One of the secondary outcome measures was clinical cure. 
This was measured using a content validated symptom 
diary, where items were generated through cognitive 
interviews with patients.17 Patients could state on their 
consent form whether they wished to be informed about 
the results of the study. This will be done using a text 
message with a short summary and a link after publica-
tion. Patients were not involved in the design of the study. 
All recruiting practices received a poster displaying infor-
mation about the trial to hang in the waiting room, so 
patients could enquire about participation in case they 
were not approached regarding this.
Point-of-care tests
Culture-only group: The ID Flexicult (SSI DIagnostica, 
Denmark) is a chromogenic agar allowing identification 
and quantification of (1) E. coli, (2) other Enterobacteri-
aceae (Gram-negative rods), (3) enterococci, (4) Proteus 
spp, (5) Staphylococcus saprophyticus and (6) Pseudomonas 
aeruginosa. The plate is inoculated with freshly voided 
urine using a 10 µL loop needle and incubated at 35°C 
overnight. It is read the following day, but negative culture 
can only be determined after 24 hours. Significant growth 
was prespecified as ≥103 colony-forming units per millil-
itre (cfu/mL) for E. coli and S. saprophyticus and ≥104 cfu/
mL for other typical uropathogens in accordance with 
European guidelines.12
Culture and susceptibility testing group: The Flexicult 
SSI-Urinary Kit (SSI Diagnostica, Denmark) is an agar 
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Table 3 Reasons for appropriate and inappropriate choice of treatment and distribution of patients between groups
Culture and 
susceptibility, n (%) Culture only, n (%)
Appropriate choice of treatment 120 (67) 121 (75)
  UTI and first-line antibiotic and pathogen susceptible 85 (47) 90 (56)
  UTI, second-line antibiotic and pathogen susceptible and first-line 
antibiotic impossible due to allergies or resistance
0 (0) 0 (0)
  No UTI and no antibiotic 35 (20) 31 (19)
Inappropriate choice of treatment 59 (33) 41 (25)
  UTI and no antibiotic 13 (7) 7 (4)
  UTI and antibiotic but uropathogen not susceptible to antibiotic 10 (6) 7 (4)
  UTI and inappropriate second-line antibiotic 3 (2) 0 (0)
  No UTI and antibiotic 33 (18) 27 (17)
The overall difference was significant as shown in table 2, but none of the individual differences was significant.
NS, non-significant; UTI, urinary tract infection.
Figure 2 Cure rates for the two groups. The level of the 
coloured lines indicates the proportion of patients still 
having symptoms. Day 0 is the evening of the day of the 
consultation. The first vertical grey line indicates initiation of 
treatment (the morning after the consultation); the second 
vertical grey line indicates the data used for calculation of 
the secondary outcome: clinical cure on day 5 (4 days after 
consultation).
dish consisting of a large compartment containing the 
same agar material as in the ID Flexicult and five small 
compartments, each containing agar with a specific antibi-
otic: (1) trimethoprim, (2) sulfamethizole, (3) ampicillin, 
(4) nitrofurantoin and (5) mecillinam. The agar plate is 
flooded with freshly voided urine for 3–5 s. Any excess 
urine is discarded. The plate is incubated and handled in 
the same way as the ID Flexicult. Significant growth was 
prespecified (advised by manufacturer) to ≥103 cfu/mL 
for any uropathogen.
reference culture in the microbiological laboratory
Urine samples were sent by special delivery service to 
the reference microbiological laboratories at the Depart-
ment of Clinical Microbiology, Copenhagen University 
Hospital, Herlev, Denmark or the Department of Clin-
ical Microbiology, Copenhagen University Hospital, 
Hvidovre, Denmark. Urine samples were analysed on 
Inoqul A Bi-plate (CHROMagar and blood agar) with 
10 µL on each half of the agar. The susceptibility pattern 
was determined on Mueller Hinton agars with disks 
containing antibiotics, including mecillinam, trimetho-
prim, nitrofurantoin, sulfamethizole, ampicillin and 
ciprofloxacin. All samples were quantified. Significant 
growth was defined as growth of ≥103 cfu/mL for E. 
coli and S. saprophyticus, ≥104 cfu/mL for other typical 
uropathogens and ≥105 cfu/mL for possible uropatho-
gens. Plates with growth of more than two uropathogens 
were labelled as mixed cultures and classified in the anal-
ysis as negatives.
randomisation and concealment of allocation
The randomisation code was produced by an online 
random number generator as permuted block randomis-
ation in blocks of 10 by the investigators. The allocation of 
each included patient was placed in an opaque, sequen-
tially numbered, sealed envelope, which was opened in 
general practice after inclusion of the patient.
Outcomes
Primary outcome: Appropriate treatment was defined 
as either (1) if the patient had UTI in the reference: 
to prescribe a first-line antibiotic to which the infecting 
pathogen was susceptible; (2) if the patient had UTI but 
was allergic to the antibiotic or the pathogen was resistant 
to all first-line antibiotics: to prescribe a second-line anti-
biotic or (3) if the patient did not have UTI in the refer-
ence: not to prescribe an antibiotic. Secondary outcomes: 
Clinical cure was defined as the patient reporting herself 
as symptom free in the symptom diary on day 5 (4 days 
after initiation of treatment). Microbiological cure was 
defined as no significant growth in the control urine 
sample after 14 days.
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statistical analysis
Sample size calculation was performed assuming the 
proportion of appropriately treated patients in the control 
group would be 70%–80%, since POC culture had proven 
quite accurate and local resistance rated to pivmecillinam 
and sulfamethizole was 6%–10% and 30%–40%, respec-
tively.14 18 To detect a statistically significant (α=0.05) 
10 percentage point difference between the two groups 
with 80% probability, assuming an intraclass correlation 
of 0.2 between patients in the same practice, a sample of 
600 patients was needed. To take possible dropouts and 
subanalyses into account, the study originally aimed at 
enrolling 750 patients.
The distributions of baseline presentation characteris-
tics were compared between the randomisation groups 
using χ2 tests. Investigated variables were: age, number 
of days with symptoms, key symptoms (dysuria, frequency 
and urge), complicating factors and reference culture 
and susceptibility test. Primary and secondary outcomes 
were analysed in logistic regression models; clustering 
within practices was adjusted for by generalised esti-
mating equations. Patient factors (age, number of days 
with symptoms, key symptoms, and complicating factors) 
and practice factors (number of GPs and organisation of 
practice) were investigated for effect modification on the 
primary outcome. All analyses were performed as inten-
tion-to-treat (ITT) analyses. The significance level was 
5%. Statistical analysis was performed with SAS V.9.4 for 
Windows V.7, SAS Institute.
results
Twenty general practices with a total of 45 GPs were 
recruited from the Copenhagen area and they screened 
851 patients for eligibility between 1 March 2015 and 1 
May 2016. Of these, 376 patients agreed to participate: 
199 were randomised to culture and susceptibility testing, 
and 177 were randomised to culture only. Thirteen 
patients were excluded from the analysis, leaving a total 
of 363 patients with data on at least one of the outcomes 
to be included in the analysis. An overview of the inclu-
sion and exclusion of patients can be seen in figure 1.
Patient characteristics and distribution between groups 
can be seen in table 1. Most of the baseline variables did 
not differ significantly between groups, but the propor-
tion of patients who were over 65 years or who had recur-
rent UTI or diabetes (complicated cases of uncomplicated 
UTI) differed significantly. The prevalence of confirmed 
UTI (significant growth of uropathogens in the reference 
standard) and susceptibility pattern in the reference stan-
dard did not differ between groups.
Three quarters (75%) of the patients were appropriately 
treated in the culture-only group and two-thirds (67%) 
were appropriately treated in the culture and suscepti-
bility testing group. This difference was significant both 
in the unadjusted analysis and when controlled for base-
line characteristics. Subgroup analyses on young patients 
without comorbidity and patients who were elderly or 
who had diabetes or recurrent UTI showed that young 
patients with no comorbidities were significantly more 
appropriately treated in the culture-only group compared 
with the culture and susceptibility group. The differ-
ence was not significant for patients who were elderly or 
who had diabetes or recurrent UTI, although culture-
only group was still superior to culture and susceptibility 
testing (table 2).
Table 3 shows the distribution of patients and the 
reasons why they were labelled as appropriately or inap-
propriately treated. Overtreatment of patients without 
UTI was the major reason for inappropriate treatment 
and was almost equally distributed between groups. 
Undertreatment was slightly higher in the culture and 
susceptibility group. Surprisingly, treatment with an anti-
biotic to which the infecting pathogen was resistant was 
higher in the culture and susceptibility group. None of 
the individual differences was significant.
Three hundred and eight patients (85%) had data for 
the secondary outcome, clinical cure on day 5. Cure rates 
were equal between groups, and there was no significant 
difference between the proportions of patients cured on 
day 5 (see table 2 and figure 2). One hundred and forty-
four patients (40%) delivered a control urine sample after 
14 days. There was no significant difference in microbio-
logical cure rate between groups.
In accordance with the protocol, we investigated 
whether practice or patient factors could modify the 
primary outcome (effect modification). Neither practice 
factors (size and organisation of participating practices) 
nor patient factors (any complicating factor, age, diabetes, 
number of UTIs and number of key symptoms at inclu-
sion) modified the effect of the intervention significantly.
Six patients in the culture-only group had the wrong 
test performed (culture and susceptibility testing). Per 
protocol analysis essentially reproduced our findings with 
culture-only still leading to 75% appropriate treatment 
and culture and susceptibility testing to 67% appropriate 
treatment (p=0.05 unadjusted and 0.02 adjusted).
DIscussIOn
Patients in the POC culture group received significantly 
more appropriate prescribing than patients in the POC 
culture and susceptibility group. There was no difference 
in clinical recovery, despite the difference in appropriate 
prescribing. This may be partly due to the fact that pivme-
cillinam has been shown to have a clinical and micro-
biological effect despite the infecting pathogen being 
resistant in vitro.5
We aimed at investigating the effect of adding suscepti-
bility testing to POC culture on the appropriate use of anti-
biotics so the RCT was the most appropriate design.19–21 
We succeeded in enrolling a sample of GPs with experi-
ence in POC culture. These GPs recruited a sample of 
patients with symptoms of uncomplicated UTI, which 
was sufficient to detect a small but significant difference 
between appropriate prescribing based on two different 
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POC culture tests. The inclusion criteria broadened 
the usual strict definition of uncomplicated UTI, which 
ensures applicability of our findings to a much broader 
group of patients in general practice. It may be contro-
versial to include patients with diabetes and recurrent 
UTI in a sample of patients with uncomplicated UTI, but 
since these conditions are very common among patients 
with suspected UTI in general practice and they could be 
safely included, we decided to include these conditions 
and investigate whether they modified the effect of the 
intervention on the outcome. Both the subgroup analysis 
and the investigation of effect modification indicated that 
these patients’ disease was not more complicated than that 
of young women with no comorbidity. We did not recruit 
our initially planned sample, but the difference between 
groups turned out to be larger than originally expected 
when sample size was calculated. A type I error in deter-
mining the superiority of the ID Flexicult is possible since 
the significance level was not overwhelming, but a type 
II error in failing to detect the expected superiority of 
the Flexicult SSI-Urinary Kit is unlikely. Subgroup analysis 
could easily be subjected to both type I and type II errors 
and should be interpreted with caution.
Bias in the interpretation of the test was low as described 
previously.22 GPs were blinded to the result of the refer-
ence at the time of deciding on treatment; POC test and 
reference were performed on the same portion of urine; 
the reference was adequate for ruling disease in or out 
and all data were included in the analysis. Allocation was 
concealed using sealed envelopes. It is very unlikely that 
GPs introduced any selection bias due to strong beliefs of 
the effect of one of the tests. Applicability of the results 
was also high, since patients, GPs and tests were very 
similar to those which would be relevant in daily prac-
tice. Patients with negative dipstick results were excluded. 
Spectrum bias should therefore be considered if the tests 
are applied to all patients regardless of their dipstick 
result.
The study was subjected to clinical review bias in the 
interpretation process, since the interpreter of the POC 
tests was not blinded to clinical history. The two groups 
did not differ in terms of number of symptoms or number 
of days with symptoms, and patient factors did not seem to 
have different effects on the two groups, so the difference 
in this bias between groups was probably minimal. Confir-
mation bias in the interpretation process could also be 
present, since treatment had to be initiated based on the 
result of the test and only patients with suspected UTI were 
included. GPs were slightly more compliant with regard 
to the familiar test (culture and susceptibility testing) 
than with the new test. However, since overtreatment was 
similar in the two groups, it does not seem to have had 
a major effect (see online supplementary appendix 1). 
The number of patients recruited in the two groups was 
not the same, but if allocation concealment was insuffi-
cient leading GPs to avoid recruiting patients when the 
patient was intended to receive culture without suscepti-
bility testing, we would have expected more patients with 
any complicating factor in the culture and susceptibility 
groups, but the opposite was the case. The unequal distri-
bution of patients between the groups was more likely 
random due to the GPs not recruiting to number. Our 
trial was open label and it is possible that ascertainment 
bias was present if GPs had a stronger belief in one of 
the tests. Six patients had the wrong test performed, 
but per-protocol analysis reproduced the ITT findings, 
suggesting that this was unintentional. The reference, 
sending urine in boric acid for culture at the microbio-
logical laboratory, has its flaws as previously described.22 
However, these flaws should have a similar effect on the 
two groups, since the distribution of growth and the resis-
tance pattern did not differ significantly between groups.
There are no previous diagnostic RCTs comparing the 
use of POC culture versus POC culture and susceptibility 
testing in general practice. A study from 2010 investigated 
five different management strategies and found differ-
ences in antibiotic use (more antibiotics were used when 
treatment was based only on symptoms) but no difference 
in patient recovery.23 They found the lowest antibiotic use 
in the group in which antibiotics were delayed (77%). In 
comparison, total antibiotic use was 76% for culture only 
and 73% for culture and susceptibility testing in this study.
The significant overall difference in appropriate 
prescribing between the groups was driven by three 
factors (none of them individually significant): first, 
undertreatment; second, treatment with an antibiotic 
to which the infecting pathogen was resistant and third, 
inappropriate choice of a second-line antibiotic. The first 
factor, undertreatment, could be partly due to a slightly 
lower sensitivity of the Flexicult SSI-Urinary Kit22 and 
partly to GPs being generally more compliant with a 
negative result in this group (see online supplementary 
appendix 1). The second factor, treatment with an anti-
biotic to which the infecting pathogen was resistant, was 
surprising and could be partly due to the fact that suscep-
tibility testing in general practice is not always accurate11 
and partly due to ID Flexicult possibly being a better test 
to identify pathogens, thereby identifying the inherent 
susceptibility pattern. Correct identification of pathogens 
is essential for determining the inherent susceptibility 
pattern, since the inherent susceptibility pattern does 
not necessarily show on the culture plate.24 The GPs in 
our study may have relied too much on their suscepti-
bility test and only looked up the inherent susceptibility 
when they were forced to do so. The study on the accu-
racy of the two tests investigated in this study showed that 
the GPs identified pathogens correctly in about 60% of 
the positive cultures.22 A post hoc analysis showed that 
the ID Flexicult was actually significantly better at iden-
tifying uropathogens than the Flexicult SSI Urinary kit. 
However, the most common uropathogen, E. coli, does 
not have inherent resistance to first-line antibiotics, so 
this second factor may just be a random finding. The 
third factor, inappropriate choice of a second-line anti-
biotic, happened in a few cases and none of them had an 
obvious reason, such as identification of resistance on the 
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practice susceptibility test or patient allergies. The factor 
expected to drive the difference between the groups: 
choice of an antibiotic to which the infecting pathogen 
was resistant, happened in few cases with no difference 
between the groups. Resistance levels in Denmark are 
low, and in countries with high resistance rates, the results 
would probably be different. It remains to be investigated 
if adding POC susceptibility testing in a high-resistance 
setting improves prescribing.
The findings of this study support current recommen-
dations that uncomplicated UTI should not have suscep-
tibility testing performed prior to initiation of treatment. 
Women generally accepted delaying treatment for 1 day 
to await the POC culture result and inappropriate treat-
ment was low in both groups. If all patients had been 
treated with first-line antibiotics based on clinical history 
and positive dipstick finding, then about 45% of patients 
would have been inappropriately treated compared with 
29% in this study (data not shown). Also, total antibi-
otic use was lower than previously described in a similar 
setting.23 Based on these results, performing POC culture 
prior to treatment for patients with uncomplicated UTI 
seems rational, but adding POC susceptibility testing 
should be reserved for those patients at high risk of a 
resistant infection or complications or for geographical 
areas with high levels of resistance.
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